According to a new report from Intel Market Research, the global Rosuvastatin Intermediates market was valued at USD 2,818 million in 2024 and is projected to reach USD 4,773 million by 2032, growing at a CAGR of 7.9% during the forecast period (2024-2032). This substantial growth is driven by rising cardiovascular disease prevalence worldwide and increasing demand for cost-effective...